MiNK Therapeutics, Inc. (NASDAQ:INKT) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. I would like to welcome everyone to the MiNK Therapeutics Third Quarter 2024 Financial Results.
Mink Therapeutics Inc. (INKT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 106,687 | $80,015 | -17% | 0% |
| 2. | Millennium Management Israel Englander | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.10 | 429 | 21,772,863 | 2023-10-16 | Filing | ||
| $1.10 | 19,373 | 21,772,434 | 2023-10-13 | Filing | ||
| $1.10 | 3,173 | 21,753,061 | 2023-10-12 | Filing | ||
| $1.09 | 15,001 | 21,749,888 | 2023-10-04 | Filing | ||
| $1.52 | 29,678 | 21,734,887 | 2023-08-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.95 | 100,000 | 1,866,400 | 2023-05-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 234,182 | $250,575 | 0% | |
| 2. | 166,666 | $178,333 | 0.01% | |
| 3. | 90,164 | $96,947 | 0% | |
| 4. | 76,457 | $81,810 | 0% | |
| 5. | 54,291 | $58,091 | 0% |
News See All
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q2 2024 Earnings Call Transcript
Operator: Good morning and welcome to MiNK Therapeutics Second Quarter 2024 Conference Call and Webcast. All participants will be in listen-only mode until question-and-answer session.
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q1 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the MiNK Therapeutics' First Quarter 2024 Conference Call and Webcast. [Operator Instructions]. Please note this event is being recorded.
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2023 Earnings Call Transcript
MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.15.
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q1 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the MiNK Therapeutics’ First Quarter 2023 Financial Results Call.
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2022 Earnings Call Transcript
Operator: Good morning, and welcome to MiNK Therapeutics' Fourth Quarter and Full Year 2022 Conference Call and Webcast.
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q3 2022 Earnings Call Transcript
Operator: Good morning, and welcome to MiNK Therapeutics' Third Quarter 2022 Conference Call and Webcast. All participants will be in a listen-only mode until the question-and-answer session.
Hedge Fund and Insider Trading News: Ian Wace, Pierre Andurand, Millennium Management, Three Arrows Capital, Lockheed Martin Corporation (LMT), PureBase Corporation (PUBC), and More
It's not just Ken Griffin who's hiring in Miami.
Billionaire Hedge Funds
